President and Chief Executive Officer @ Neurogastrx, Inc.
Chief Business Officer @ AmpliPhi Biosciences
Vice President, Corporate Strategy and Business Development @ AmpliPhi Biosciences
B.S., Biology @
Mr. Phillips is an experienced biotechnology executive whose experience spans the continuum from preclinical drug research to product launch and commercialization. Mr. Phillips is President and Chief Executive Officer at Neurogastrx Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for gastrointestinal disorders. Prior to Neurogastrx, Mr. Phillips was Chief Business Officer
Mr. Phillips is an experienced biotechnology executive whose experience spans the continuum from preclinical drug research to product launch and commercialization. Mr. Phillips is President and Chief Executive Officer at Neurogastrx Inc., a biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for gastrointestinal disorders. Prior to Neurogastrx, Mr. Phillips was Chief Business Officer of AmpliPhi Biosciences, where he played a pivotal role in establishing the company's manufacturing and led the company to its NYSE listing. Previously, he served as Director, Business Development at Depomed, Inc., a specialty pharmaceutical company where he was focused on the global licensing of the Company's portfolio of approved products and the proprietary formulation technology platform. Prior to Depomed, Mr. Phillips led the business development, intellectual property and investor relations functions at Osteologix, Inc. where he successfully prosecuted and defended the company’s worldwide patent estate which resulted in a global licensing deal for a family of novel osteoporosis therapies with a major multinational pharmaceutical company. Prior to Osteologix, his biotechnology work included Insmed Incorporated, where he managed project teams of preclinical programs, initiated and led in-house investor and public relations, managed business development activities, and helped launch and commercialize a novel biologic agent. Mr. Phillips has significant experience in corporate financing having successfully managed both public and private equity and debt offerings. He has a B.S. in Biology from Hampden-Sydney College and an MBA from The Mason School of Business at the College of William and Mary.
Specialties: Corporate strategy, financing, competitive analysis, intellectual property management, investor relations, corporate compliance, strategic planning, business development, licensing, mergers and acquisitions
President and Chief Executive Officer @ From October 2015 to Present (3 months) Richmond, Virginia AreaChief Business Officer @ From October 2014 to October 2015 (1 year 1 month) Vice President, Corporate Strategy and Business Development @ From October 2013 to October 2014 (1 year 1 month) Director, Business Development @ From August 2011 to October 2013 (2 years 3 months) Sr. Director, Corporate Development @ From June 2007 to August 2011 (4 years 3 months) Biotechnology Consultant @ From March 2007 to May 2007 (3 months) Area Manager @ From March 2006 to March 2007 (1 year 1 month) Director, Investor Relations @ From September 2001 to March 2006 (4 years 7 months) Research Scientist @ From January 1998 to August 2001 (3 years 8 months)
MBA @ The College of William and Mary - The Mason School of Business From 2007 to 2008 B.S., Biology @ Hampden-Sydney College From 1993 to 1997 The Collegiate School From 1986 to 1993 Baxter Phillips, III is skilled in: Mergers, Clinical Development, Biotechnology, Drug Development, Strategic Planning, Commercialization, Investor Relations, Product Launch, Pharmaceutical Industry, Competitive Analysis, Licensing, Oncology, Drug Discovery, Business Development, Private Equity
Looking for a different
Baxter Phillips, III?
Get an email address for anyone on LinkedIn with the ContactOut Chrome extension